siRNA targeting PLK-1 induces apoptosis of synoviocytes in rheumatoid arthritis

被引:16
作者
Wada, Makoto
Kawahito, Yutaka
Kimura, Shinya
Kohno, Masataka
Ishino, Hidetaka
Kimura, Mizuho
Omoto, Atsushi
Yamamoto, Aihiro
Hamaguchi, Masahide
Tsubouchi, Yasunori
Tokunaga, Daisaku
Hojo, Tatsuya
Ashihara, Eishi
Maekawa, Taira
Yoshikawa, Toshikazu
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan
关键词
siRNA; PLK-1; apoptosis; synoviocyte; rheumatoid arthritis;
D O I
10.1016/j.bbrc.2007.03.190
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Polo-like kinase-1 (PLK-1) is a member of the PLK family and participates in the control of cell mitosis. Here, we show that immunoreactive PLK-1 is strongly expressed in synoviocytes and some infiltrative mononuclear cells in synovial tissues from patients with rheumatoid arthritis (RA), while patients with osteoarthritis and injury show little or no expression of PLK-1 in synovial tissues. Western blot analysis shows that PLK is expressed and its expression is enhanced by IL-1 beta in RA synoviocytes. IL-1 beta also enhanced the cell growth of RA synoviocytes. Moreover, siRNA targeted against PLK-1 significantly decreases the expression of PLK-1 of RA synoviocytes stimulated by IL-1 beta and suppresses the proliferation of these synoviocytes through apoptosis. These findings suggest that PLK-1 plays a critical role in the proliferation of RA synoviocytes leading to bone destruction, and siRNA against PLK-1 is potentially useful for the treatment of RA. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 31 条
[1]
CYTOKINES IN CHRONIC INFLAMMATORY ARTHRITIS .5. MUTUAL ANTAGONISM BETWEEN INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA ON HLA-DR EXPRESSION, PROLIFERATION, COLLAGENASE PRODUCTION, AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR PRODUCTION BY RHEUMATOID-ARTHRITIS SYNOVIOCYTES [J].
ALVAROGRACIA, JM ;
ZVAIFLER, NJ ;
FIRESTEIN, GS .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (06) :1790-1798
[2]
Polo-like kinases and the orchestration of cell division [J].
Barr, FA ;
Silljé, HHW ;
Nigg, EA .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (06) :429-440
[3]
Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[4]
Gene therapy for arthritis - What next? [J].
Evans, Christopher H. ;
Ghivizzani, Steven C. ;
Robbins, Paul D. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (06) :1714-1729
[6]
Effects of bisphosphonates on joint damage and bone loss in rat adjuvant-induced arthritis [J].
Harada, H ;
Nakayama, T ;
Tanaka, T ;
Katsumata, T .
INFLAMMATION RESEARCH, 2004, 53 (02) :45-52
[7]
Hirabayashi K, 1999, CANCER RES, V59, P4325
[8]
Hollander J L, 1970, Md State Med J, V19, P62
[9]
INDUCTION AND DOWN-REGULATION OF PLK, A HUMAN SERINE/THREONINE KINASE EXPRESSED IN PROLIFERATING CELLS AND TUMORS [J].
HOLTRICH, U ;
WOLF, G ;
BRAUNINGER, A ;
KARN, T ;
BOHME, B ;
RUBSAMENWAIGMANN, H ;
STREBHARDT, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) :1736-1740
[10]
High expression of human uroplakin Ia in urinary bladder transitional cell carcinoma [J].
Kageyama, S ;
Yoshiki, T ;
Isono, T ;
Tanaka, T ;
Kim, CJ ;
Yuasa, T ;
Okada, Y .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (05) :523-531